tiprankstipranks
Oramed Pharmaceuticals (ORMP)
NASDAQ:ORMP
Holding ORMP?
Track your performance easily

Oramed Pharm (ORMP) Income Statement

511 Followers

Oramed Pharm Income Statement

Last quarter (Q ), Oramed Pharm's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Oramed Pharm's net income was $-19.62M. See Oramed Pharm’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Aug 21Aug 20
Total Revenue
-$ 1.34M$ 2.70M$ 904.00K$ 2.70M$ 2.71M
Cost of Revenue
------
Gross Profit
-$ 1.34M$ 2.70M-$ 2.70M$ 2.71M
Operating Expense
$ 13.06M$ 17.11M$ 43.30M$ 13.23M$ 124.00K$ 14.47M
Operating Income
$ -13.06M$ -15.77M$ -40.60M$ -12.33M$ -124.00K$ -11.76M
Net Non Operating Interest Income Expense
$ -4.36M$ -4.59M$ -3.56M$ 71.00K$ 130.00K$ 552.00K
Other Income Expense
$ 12.80M$ 16.27M$ -630.00K-$ -223.00K$ 444.00K
Pretax Income
$ 11.23M$ 5.09M$ -37.66M$ -12.26M$ 227.00K$ -12.20M
Tax Provision
$ 2.77M-$ 100.00K---
Earnings From Equity Interest Net Of Tax
$ 1.65M$ 824.00K----
Net Income Common Stockholders
$ 4.46M$ 5.53M$ -36.56M$ -11.67M$ -22.24M$ 11.51M
Basic EPS
$ 0.11$ 0.14$ 0.94$ -0.31$ 0.78$ 0.56
Diluted EPS
$ 0.11$ 0.14$ 0.94$ -0.31$ 0.78$ 0.56
Basic Average Shares
$ 163.24M$ 40.32M$ 39.00M$ 37.11M$ 28.47M$ 20.53M
Diluted Average Shares
$ 165.61M$ 40.57M$ 39.00M$ 37.11M$ 28.47M$ 20.53M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 13.06M$ 17.11M$ 43.30M$ 13.23M$ 124.00K$ 14.47M
Net Income From Continuing And Discontinued Operation
$ 4.46M$ 5.53M$ -36.56M$ -11.67M$ -22.24M$ -11.51M
Normalized Income
$ 8.50M$ 7.93M-$ -11.67M$ 179.33K-
Interest Expense
---$ 87.00K--
EBIT
$ 9.22M$ 7.13M$ -37.66M$ -12.17M$ -24.22M$ -11.76M
EBITDA
$ 9.44M$ 7.32M$ -37.61M$ -12.15M$ -24.15M$ -11.75M
Currency in USD

Oramed Pharm Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis